[go: up one dir, main page]

WO2003010184A3 - Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose - Google Patents

Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose Download PDF

Info

Publication number
WO2003010184A3
WO2003010184A3 PCT/US2002/003553 US0203553W WO03010184A3 WO 2003010184 A3 WO2003010184 A3 WO 2003010184A3 US 0203553 W US0203553 W US 0203553W WO 03010184 A3 WO03010184 A3 WO 03010184A3
Authority
WO
WIPO (PCT)
Prior art keywords
caspase
diablo
xiap
smac
conserved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/003553
Other languages
English (en)
Other versions
WO2003010184A2 (fr
Inventor
Emad S Alnemri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Priority to AU2002253908A priority Critical patent/AU2002253908A1/en
Priority to IL15716802A priority patent/IL157168A0/xx
Publication of WO2003010184A2 publication Critical patent/WO2003010184A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003010184A3 publication Critical patent/WO2003010184A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des peptides et des polypeptides associés à la caspase-9 et capables de se fixer à un inhibiteur de protéine d'apoptose (IAP), ainsi qu'un mutant de caspase-9, qui ne subissent pas de traitement normal et ne se fixent pas à une IAP. L'invention concerne en outre des molécules d'acide nucléique, notamment des vecteurs d'expression, qui codent lesdits peptides et polypeptides. Lesdits peptides et polypeptides sont utilisés pour provoquer l'apoptose et identifier des inhibiteurs et des amplificateurs d'apoptose.
PCT/US2002/003553 2001-02-08 2002-02-06 Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose Ceased WO2003010184A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002253908A AU2002253908A1 (en) 2001-02-08 2002-02-06 A conserved xiap-interaction motif in caspase-9 and smac/diablo for mediating apoptosis
IL15716802A IL157168A0 (en) 2001-04-12 2002-03-28 Method and apparatus for measuring the position, shape, size and intensity distribution of the effective focal spot of an x-ray tube

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26796601P 2001-02-08 2001-02-08
US60/267,966 2001-02-08

Publications (2)

Publication Number Publication Date
WO2003010184A2 WO2003010184A2 (fr) 2003-02-06
WO2003010184A3 true WO2003010184A3 (fr) 2003-08-14

Family

ID=23020873

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/003553 Ceased WO2003010184A2 (fr) 2001-02-08 2002-02-06 Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose

Country Status (2)

Country Link
AU (1) AU2002253908A1 (fr)
WO (1) WO2003010184A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835393B2 (en) 2008-08-02 2014-09-16 Genentech, Inc. Inhibitors of IAP
US8907092B2 (en) 2007-04-30 2014-12-09 Genentech, Inc. Inhibitors of IAP
US9040706B2 (en) 2004-12-20 2015-05-26 Genentech, Inc. Pyrrolidine inhibitors of IAP

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723122B1 (fr) 2004-03-01 2014-11-19 Board of Regents, The University of Texas System Petites molécules dimères inductrices d'apoptose
WO2005094818A1 (fr) 2004-03-23 2005-10-13 Genentech, Inc. Inhibiteurs azabicyclo-octane de l'iap
CN101035802A (zh) 2004-07-02 2007-09-12 健泰科生物技术公司 Iap抑制剂
WO2007106192A2 (fr) 2005-12-19 2007-09-20 Genentech, Inc. Inhibiteurs iap (inhibiteurs de l'apoptose)
WO2008079735A1 (fr) 2006-12-19 2008-07-03 Genentech, Inc. Inhibiteurs imidazopyridine de iap

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE PIR [online] 16 July 1999 (1999-07-16), AHRENS C.A. ET AL., XP002962285, Database accession no. (T10375) *
KIPP R.A. ET AL.: "Molecular targeting of inhibitor of apoptosis based on small molecule mimics of natural binding partners", BIOCHEM., vol. 41, 2002, pages 7344 - 7349, XP002962287 *
LIU Z. ET AL.: "Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain", NATURE, vol. 408, no. 21, 28 December 2000 (2000-12-28), pages 1004 - 1008, XP002909550 *
SRINIVASULA S.M. ET AL.: "A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis", NATURE, vol. 410, 1 March 2001 (2001-03-01), pages 112 - 116, XP002962286 *
VIROLOGY, vol. 229, 1997, pages 381 - 399 *
WRIGHT C.W. ET AL.: "Sequence requirements of Hid binding and apoptosis regulation in the Baculovirus inhibitor of apoptosis OP-IAP", J. BIOL. CHEM., vol. 277, no. 4, 25 January 2002 (2002-01-25), pages 2454 - 2462, XP002962288 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040706B2 (en) 2004-12-20 2015-05-26 Genentech, Inc. Pyrrolidine inhibitors of IAP
US8907092B2 (en) 2007-04-30 2014-12-09 Genentech, Inc. Inhibitors of IAP
US8835393B2 (en) 2008-08-02 2014-09-16 Genentech, Inc. Inhibitors of IAP

Also Published As

Publication number Publication date
AU2002253908A1 (en) 2003-02-17
WO2003010184A2 (fr) 2003-02-06

Similar Documents

Publication Publication Date Title
AU2003249920A1 (en) Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
WO2002016412A3 (fr) Polypeptides de liaison pour proteine stimulatrice des lymphocytes b (blys)
WO1999058571A3 (fr) Proteine hybride pour l'inhibition de la degranulation des mastocytes et son utilisation
WO2002016418A3 (fr) Peptide ou polypeptide capable de liaison avec l'inhibiteur de la proteine de l'apoptose
WO2004061080A3 (fr) Polypeptides lies au stress et utilisation desdits polypeptides
WO2002030959A3 (fr) Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci
WO2003010184A3 (fr) Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose
WO2003057708A3 (fr) Proteines de fusion
BRPI0409557A (pt) proteìna inibidora recombinante de calicreìna, seqüência de dna, vetor de expressão, célula hospedeira, composição farmacêutica e seu uso, método de produção de proteìna inibidora recombinante de calicreìna e kit de diagnóstico para detecção de calicreìna
WO2002040683A3 (fr) Proteines kinase humaines isolees, molecules d'acides nucleiques codant pour des proteines kinase humaines et utilisations
WO2005000883A8 (fr) Variantes de la proteine a des staphylocoques et procedes s'y rapportant
WO2003087145A3 (fr) Nouveaux polypeptides purifies impliques dans la detection de densite cellulaire
AU2003902414A0 (en) Flowering induction
WO2000042063A3 (fr) Peptides pour l'inhibition des proteines noyaux du virus de l'hepatite b
WO2003060103A3 (fr) Polypeptides, polynucleotides a domaine minimal de liaison a l'adn, et utilisations correspondantes
WO2006126198A3 (fr) Fragments de terminus c de molecule arts t mimetiques
WO2002070699A3 (fr) Nouveaux cofacteurs du recepteur alpha des oestrogenes et procedes d'utilisation
WO2002004644A3 (fr) Aspartyl-protease
WO2003074675A3 (fr) Proteines de type ras humaines isolees, molecules d'acide nucleique codant ces proteines de type ras humaines et leurs utilisations
WO2002022824A3 (fr) Genes de ashbya gossypii codant pour des proteines participant au transport membranaire
WO2002024748A3 (fr) Proteines de transport humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisations correspondantes
WO2002046217A3 (fr) Proteines humaines de transport isolees, molecules d'acide nucleique codant pour ces proteines humaines de transport et utilisations desdites proteines
WO2002022823A3 (fr) Proteines participant a la reponse au stress et genes provenant de ashbya gossypii codant pour ces proteines
WO2002042436A3 (fr) Proteines phosphatases humaines et molecules d'acide nucleique isolees, codant des proteines phosphatases humaines, et leurs utilisations
WO2002079494A3 (fr) Proteines humaines isolees de type ras, molecules d'acides nucleiques codant ces dernieres et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP